Gentex Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 6, 2026, reporting third-quarter net sales of $647,709,651 and net income attributable to the company of $90,564,884.

Key Highlights

  • Net sales: $647,709,651 for the three months ended September 30, 2026, compared with $655,236,055 in the same period of 2025.
  • Net income attributable to Gentex: $90,564,884 for Q3 2026, versus $100,967,910 in Q3 2025.
  • Diluted EPS: $0.43 for the third quarter of 2026, compared with $0.46 for the third quarter of 2025.
  • Nine-month net sales: $1,974,452,482 for the nine months ended September 30, 2026, up from $1,889,867,355 in the prior-year period.
  • Impairment charges: $3,000,000 recorded in Q3 2026 and $5,800,000 for the nine months ended September 30, 2026, with no comparable charges in 2025.
  • Cash dividends declared per share: $0.120 for the quarter and $0.360 for the nine-month period, unchanged from the prior-year periods.
  • Shares outstanding: 205,326,516 shares of common stock as of October 23, 2026.

Gentex Reports Lower Q3 2026 Earnings Amid Impairment Charges and Investment Losses

According to the filing, Gentex Corporation (NASDAQ:GNTX) reported third-quarter 2026 net sales of $647,709,651, a decrease from $655,236,055 in the third quarter of 2025. Gross profit for the quarter was $216,330,677, compared with $225,166,737 a year earlier. Income from operations was reported at $115,059,201 for Q3 2026 versus $122,326,938 in Q3 2025. The company disclosed impairment charges of $3,000,000 in the quarter, which had no counterpart in the prior-year period.

The filing also disclosed that total other loss, net was $(7,842,477) for the three months ended September 30, 2026, compared with $(1,756,230) in the same period of 2025. This was driven in part by investment loss, net of $(1,742,858) for Q3 2026 versus investment income of $542,055 in Q3 2025. As a result, income before provision for income taxes was $107,216,724 for the third quarter of 2026, down from $120,570,708 in Q3 2025.

For the nine-month period ended September 30, 2026, Gentex reported net income attributable to the corporation of $303,709,445, compared with $291,881,539 for the same period in 2025, with diluted earnings per share of $1.44 versus $1.31. The company's total assets as of September 30, 2026 stood at $2,940,485,369, compared with $2,928,592,834 as of December 31, 2025. Total shareholders' investment was $2,483,905,127 at September 30, 2026, versus $2,487,829,724 at year-end 2025. The filing noted the company is classified as a large accelerated filer and is not a shell company.

What Was Disclosed

Gentex filed a quarterly report covering operations for the three and nine months ended September 30, 2026, disclosing revenue, earnings, impairment charges, balance sheet data, and per-share figures, with 205,326,516 common shares outstanding as of October 23, 2026.